Replacing Sigma-Aldrich CPR CDS005940: Bulk 6-Chloroimidazo[1,2-b]pyridazine Scale-Up

Transitioning from Milligram-Scale Hydrochloride Salt Reference Standards to Kilogram-Scale Free-Base Intermediates

When scaling up from a reference standard like Sigma-Aldrich CPR CDS005940, which is supplied as the hydrochloride salt, to bulk quantities of the free base 6-chloroimidazo[1,2-b]pyridazine (CAS 6775-78-6), several critical process chemistry considerations emerge. The hydrochloride salt (C6H5Cl2N3, MW 190.03) is convenient for analytical method development and small-scale reactions, but the free base (C6H4ClN3, MW 165.58) is often preferred in subsequent synthetic steps to avoid counter-ion interference. Our team at NINGBO INNO PHARMCHEM CO.,LTD. has extensive field experience in executing this transition seamlessly, ensuring that the imidazo[1,2-b]pyridazine 6-chloro core structure is preserved without compromising reactivity.

One non-standard parameter we routinely monitor is the free base's tendency to undergo slight discoloration upon prolonged storage under ambient light, even in the absence of moisture. This is not a purity issue but rather a trace photo-oxidation phenomenon that can be mitigated by storing the material in amber glass or opaque HDPE containers. For process chemists, this means that visual appearance alone is not a reliable indicator of quality; always refer to the batch-specific COA for assay and impurity profile. Our bulk 6-chloroimidazo[1,2-b]pyridazine is produced under controlled conditions to minimize such degradation, and we provide detailed handling recommendations to maintain integrity during transfer and storage.

Mitigating Residual Chloride Counter-Ion Fouling in Continuous Flow Reactors During Scale-Up

In continuous flow processes, residual chloride ions from incomplete salt-to-free-base conversion can lead to fouling of reactor surfaces, particularly in stainless steel or Hastelloy systems. This is a common pitfall when scaling up 6-chloro-imidazo[1,2-b]pyridazine synthesis. Our manufacturing process includes a rigorous aqueous workup with multiple water washes and a final treatment with a weak base to ensure chloride levels are below 50 ppm, as confirmed by ion chromatography. This step is crucial for maintaining the longevity of flow reactor components and avoiding unexpected downtime.

For procurement managers, this translates to a more reliable supply chain: our material is ready for direct use in flow chemistry without additional purification. We also offer custom packaging in 210L drums or IBC totes, with nitrogen blanketing to prevent moisture ingress during transport. For a deeper dive into impurity control, refer to our detailed analysis on 6-chloroimidazo[1,2-b]pyridazine impurity profiles and how they impact downstream reactions.

Solvent Switching Protocols to Maintain Reaction Kinetics and Prevent Catalyst Deactivation

Many literature procedures for imidazo(1,2-b)pyridazine 6-chloro utilize polar aprotic solvents like DMF or DMSO, which can be problematic at scale due to high boiling points and potential for peroxide formation. Our process R&D team has developed robust solvent switching protocols that allow customers to replace these solvents with more industrially friendly alternatives such as 2-MeTHF or cyclopentyl methyl ether (CPME) without sacrificing reaction rates. This is particularly important in palladium-catalyzed cross-coupling reactions where the heterocyclic building block serves as an electrophilic partner.

We have observed that trace DMF residues from the original synthesis can poison certain catalysts, leading to stalled reactions. Our manufacturing process avoids DMF entirely, using a proprietary solvent system that yields a product with no detectable amide solvents by GC headspace. This field-tested approach ensures that your pharmaceutical intermediate performs consistently in antibiotic synthesis and other applications. For a comprehensive look at how solvent residues affect coupling efficiency, see our article on 6-chloro-imidazo[1,2-b]pyridazine impurity profiles and supply.

Drop-in Replacement Strategy: Matching Sigma-Aldrich CPR CDS005940 Specifications Without REACH Claims

Our 6-chloroimidazo[1,2-b]pyridazine free base is designed as a drop-in replacement for the hydrochloride salt reference standard in terms of reactivity and purity. While we do not claim EU REACH compliance, our product meets or exceeds the typical purity specifications of the Sigma-Aldrich material (≥95% by HPLC) and is available in bulk quantities up to multi-kilogram scale. The key difference is the physical form: our free base is a crystalline solid with a melting point of 108–110°C, whereas the hydrochloride salt is often a powder. This change in form may require minor adjustments to charging procedures, but our technical support team can provide guidance.

To ensure a seamless transition, we recommend the following step-by-step troubleshooting process when first qualifying our material:

• Step 1: Analytical Cross-Check. Run HPLC under the same conditions used for the reference standard. The retention time of the free base will be slightly different due to the absence of the chloride counter-ion; adjust the method if necessary.
• Step 2: Karl Fischer Titration. Determine water content. Our specification is ≤0.5%, but if the material has been exposed to ambient humidity, it may pick up moisture. Dry under vacuum at 40°C if needed.
• Step 3: Test Reaction in a Model System. Perform a small-scale Suzuki coupling or amination reaction using your standard protocol. Compare conversion and impurity profile to historical data with the hydrochloride salt.
• Step 4: Adjust Base Equivalents. Since the free base does not require neutralization of HCl, you may need to reduce the amount of exogenous base (e.g., K2CO3) by one equivalent.
• Step 5: Scale-Up Confirmation. Run a 10x scale-up batch and monitor for any exothermic events or unexpected by-products. Our material has been validated in reactions up to 100 kg scale.

By following these steps, you can confidently replace the Sigma-Aldrich CPR CDS005940 with our bulk intermediate, achieving identical or better yields while significantly reducing costs.

Supply Chain Reliability and Cost-Efficiency for Bulk 6-Chloroimidazo[1,2-b]pyridazine Procurement

As a global manufacturer of heterocyclic building blocks, NINGBO INNO PHARMCHEM CO.,LTD. maintains a robust inventory of 6-chloroimidazo[1,2-b]pyridazine to support pharmaceutical R&D and production. Our manufacturing process is vertically integrated, starting from readily available raw materials, which insulates our customers from supply disruptions. We offer competitive bulk pricing with tiered discounts for annual contracts, and our logistics team can arrange shipment in 210L drums or IBC totes to meet your production schedule.

We understand that high purity reagent consistency is critical. Every batch is accompanied by a comprehensive COA including assay, water content, residual solvents, and impurity profile. For projects requiring custom synthesis of derivatives or analogs, our R&D team can collaborate under confidentiality. Our goal is to be your long-term partner for pharmaceutical intermediates, providing not just chemicals but process knowledge.

Frequently Asked Questions

What is the typical yield when converting the hydrochloride salt to the free base?

The conversion is essentially quantitative if performed correctly. We achieve >98% recovery by neutralizing an aqueous solution of the salt with sodium bicarbonate, extracting with dichloromethane, and crystallizing from heptane/ethyl acetate. Losses are primarily mechanical.

What solvent residue limits should I specify to avoid interference in downstream coupling reactions?

We recommend specifying ≤100 ppm for DMF and DMSO, and ≤500 ppm for other Class 2 solvents. Our standard product meets these limits, but if your process is particularly sensitive, we can provide a custom specification with lower thresholds.

How should I handle the material to prevent hygroscopic degradation during transfer?

The free base is not highly hygroscopic, but it can absorb moisture over time. We package under nitrogen in sealed containers. When opening, minimize exposure to ambient air, and if the material will be used over multiple campaigns, consider sub-packaging into smaller, dry containers under inert atmosphere.

Can you provide the material in a specific particle size distribution for continuous processing?

Yes, we can mill or sieve the product to meet your requirements. Standard material is a crystalline powder with D90 < 200 µm, but we can achieve finer or more uniform distributions upon request.

What is the shelf life of the bulk free base?

When stored in the original unopened container at 2–8°C and protected from light, the material is stable for at least 24 months. We recommend retesting after this period.

Sourcing and Technical Support

In summary, transitioning from Sigma-Aldrich CPR CDS005940 to bulk 6-chloroimidazo[1,2-b]pyridazine free base from NINGBO INNO PHARMCHEM CO.,LTD. is a straightforward process that can yield significant cost savings and supply security. Our team is ready to support your scale-up with technical data, sample quantities, and process optimization advice. For custom synthesis requirements or to validate our drop-in replacement data, consult with our process engineers directly.